EDGE
Get a demo
Log In

C2i Genomics

Recent Updates

M&A
Feb 6, 2024
Veracyte acquires C2i Genomics to add whole-genome minimal residual disease capabilities to its diagnostics platform
Precision Medicine
M&A
Jan 8, 2024
Veracyte Acquires C2i Genomics for USD 70 million with additional USD 25 million tied to performance over next two years
Precision Medicine

Company Brief


HQ location:
180 Varick Street 6th Floor New York NY USA
Founded year:
2019
Employees:
11-50
Total Funding:
USD 112.0 million
Last Funding
USD 100.0 million, Apr 2021

Funding


Investors


No investor data is available

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.